MedTrace Logo

The Benefits Of Cryoablation In Patients Undergoing Total Knee Arthroplasty

NCT06991231 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 215

Last updated 2026-04-03

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of cryoablation use on patient-reported outcomes (PROMs) and opioid consumption following total knee arthroplasty. This is a randomized study that will involve a 1:1 randomization to total knee arthroplasty +/- cryoablation.

Conditions

  • Post-Operative Pain
  • Total Knee Arthroplasty

Interventions

PROCEDURE

Total knee arthroplasty (TKA)

Administered as part of patient standard of care.

DEVICE

Cryoablation

Cryoablation will be administered on the leg of the knee indicated for surgery.

Sponsors & Collaborators

Principal Investigators

  • Joshua Rozell, MD · NYU Langone Health

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-13
Primary Completion
2026-09-01
Completion
2027-01-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06991231 on ClinicalTrials.gov